Congratulations Shahrzad for passing the MSc exam with flying colours. We enjoyed your inquisitive mind and commitment to research at the highest level. It was a pleasure to serve as the external examiner along side my dear colleague and supervisor Chris and our Chair Arthur

Congrats to Shahrzad Khajehzadehshoushtar Shahrzad Shoushtar for an outstanding MSc defence! Shar is nominated for a thesis prize for a carefully crafted document, voluminous work, + high-level discussion Watch for Shar's publication on mitochondrial therapy in ovarian cancer cachexia

Grateful to be part of this team and to have such amazing teachers the past 2 years 😁

NEW preprint: Shivam Gandhi in our lab shows cardiac fibrosis in a young mouse model of Duchenne muscular dystrophy occurs in 2 of 4 chambers. Why not all 4? Remarkably, this fibrosis is completely prevented by a novel adiponectin receptor agonist ALY688. biorxiv.org/content/10.110…

We just uploaded our next preprint on cancer-cachexia. Shahrzad Khajehzadehshoushtar discovered 'the mitochondrial-targeted antioxidant SkQ1 prevents mitochondrial-linked apoptosis but not necroptosis or skeletal muscle atrophy in ovarian cancer' ...why is apoptosis active?

Our 3rd new manuscript this week: Luca Delfinis, PhD found a mitochondrial-targeted compound partially prevents muscle weakness without preventing atrophy in ovarian cancer. This opens a new direction for therapies targeting muscle ‘quality’. biorxiv.org/content/10.110…

We're excited to see each of our 3 preprints last week pass 100 downloads. Please send feedback about this work on preclinical therapy development in Duchenne muscular dystrophy and ovarian cancer cachexia tinyurl.com/4fx3u2pn tinyurl.com/bdzxxmr6 tinyurl.com/2bakuby8